908 Devices (MASS) Other Non-Current Liabilities (2020 - 2026)
908 Devices' (MASS) quarterly Other Non-Current Liabilities came in at $30000.0 in Q1 2026, down 99.37% year-on-year from $4.8 million in Q1 2025, and little changed on a QoQ basis from $30000.0 in Q4 2025.
908 Devices (MASS) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends
908 Devices (MASS) has 7 years of Other Non-Current Liabilities data on file, last reported at $30000.0 in Q1 2026.
- On a quarterly basis, Other Non-Current Liabilities fell 99.37% year-over-year to $30000.0 in Q1 2026; TTM through Mar 2026 was $30000.0, a 99.37% decrease from a year earlier, with the FY2025 full-year figure at $30000.0, down 98.69% from the prior year.
- Other Non-Current Liabilities for Q1 2026 stood at $30000.0, roughly flat from $30000.0 in the prior quarter.
- Over the last five years, Other Non-Current Liabilities for MASS reached as high as $15.5 million in Q2 2024 and fell as low as $30000.0 in Q3 2025.
- Historically, Other Non-Current Liabilities has averaged $2.5 million across 5 years, with a median of $542000.0 in 2022.
- Across the five-year window, Other Non-Current Liabilities soared 9835.9% in 2024 and plunged 99.37% in 2026, its largest moves.
- Year by year, Other Non-Current Liabilities stood at $555000.0 in 2022, then plunged by 71.89% to $156000.0 in 2023, then surged by 1364.1% to $2.3 million in 2024, then plunged by 98.69% to $30000.0 in 2025, then changed by 0.0% to $30000.0 in 2026.
- Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $30000.0 in Q1 2026, $30000.0 in Q4 2025, and $30000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | 908 Devices | 261.78 Mn | 150.04 Mn | 6.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30,000.00 |
| Dec 31, 2025 | 30,000.00 |
| Sep 30, 2025 | 30,000.00 |
| Mar 31, 2025 | 4.78 Mn |
| Dec 31, 2024 | 2.28 Mn |
| Sep 30, 2024 | 3.36 Mn |
| Jun 30, 2024 | 15.50 Mn |
| Jun 30, 2023 | 156,000.00 |
| Mar 31, 2023 | 125,000.00 |
| Dec 31, 2022 | 555,000.00 |
| Sep 30, 2022 | 542,000.00 |
| Sep 30, 2021 | 194,000.00 |
| Jun 30, 2021 | 194,000.00 |
| Mar 31, 2021 | 194,000.00 |
| Dec 31, 2020 | 194,000.00 |